Patient Guide: Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 14 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06714591
Status: 🟢 Enrolling Now
Condition: Relapsed/Refractory Acute Myeloid Leukemia
Phase: PHASE1

Where You Can Participate

This study is available at 14 locations across the country.

Top locations include:
  • • Duarte, California
  • • Los Angeles, California
  • • New Haven, Connecticut
  • • And 11 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 - Join Clinical Trial NCTNCT06714591

How to Join This Clinical Trial - NCTNCT06714591

Learn how to participate in this PHASE1 trial studying an investigational therapy for Relapsed/Refractory Acute Myeloid Leukemia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Relapsed/Refractory Acute Myeloid Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Relapsed/Refractory Acute Myeloid Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06714591 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Duarte, California 91010 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Los Angeles, California 90095 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

New Haven, Connecticut 06511 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49546 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45236 - United States

Status: RECRUITING

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: RECRUITING

Clinical Research Site

Eugene, Oregon 24224 - United States

Status: RECRUITING

Clinical Research Site

Nashville, Tennessee 37203 - United States

Status: RECRUITING

Clinical Research Site

Houston, Texas 77030 - United States

Status: RECRUITING

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Relapsed/Refractory Acute Myeloid Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships